genXone S.A. (WSE:GX1)
Poland
· Delayed Price · Currency is PLN 5.54
-0.06 (-1.07%)
At close: Jul 11, 2025, 4:50 PM CET
genXone Market Cap
genXone has a market cap or net worth of 18.31 million as of July 14, 2025. Its market cap has decreased by -8.65% in one year.
Market Cap
18.31M
Enterprise Value
13.43M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.54
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 18.31M, a decrease of -87.08%. That is a compound annual growth rate of -34.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 18.31M | -10.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | 69.13M | -51.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.06B |
| Voxel | 1.80B |
| Synektik Spólka Akcyjna | 1.68B |
| Celon Pharma | 1.24B |
| Ryvu Therapeutics | 712.10M |
| Centrum Medyczne ENEL-MED | 557.12M |
| Selvita | 523.13M |
| Bioceltix | 510.17M |